Celularity (CELUW) Tax Provisions (2019 - 2023)
Celularity (CELUW) reported Tax Provisions of $10000.0 for Q4 2023, down 23.08% year-over-year from $13000.0 in Q4 2022, and down 23.08% quarter-over-quarter from $13000.0 in Q4 2022.
Celularity (CELUW) Tax Provisions (2019 - 2023) Analysis & Trends
Celularity (CELUW) has 5 years of Tax Provisions data on file, last reported at $10000.0 in Q4 2023.
- Tax Provisions for Q4 2023 came in at $10000.0, down 23.08% year-over-year; the trailing twelve-month figure through Sep 2024 was $10000.0 (down 23.08% YoY), and the FY2025 annual result was $3000.0, changed N/A from the prior year.
- Tax Provisions slipped to $10000.0 in Q4 2023 per CELUW's latest filing, from $13000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $298032.0 in Q3 2019 and troughed at -$69000.0 in Q4 2020.
- A 5-year average of $63692.8 and a median of $16000.0 in 2020 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2020 and 2021: Tax Provisions sank 134.24% in 2020, then jumped 214.49% in 2021.
- A 5-year view of Tax Provisions shows it stood at $201523.0 in 2019, then slumped by 134.24% to -$69000.0 in 2020, then surged by 128.99% to $20000.0 in 2021, then tumbled by 35.0% to $13000.0 in 2022, then fell by 23.08% to $10000.0 in 2023.
- Business Quant data shows CELUW's Tax Provisions at $10000.0 in Q4 2023, $13000.0 in Q4 2022, and -$17000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celularity | - | - | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 13,000.00 |
| Sep 30, 2022 | -17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Jun 30, 2021 | 43,700.00 |
| Mar 31, 2021 | -43,700.00 |
| Dec 31, 2020 | -69,000.00 |
| Sep 30, 2020 | 15,000.00 |
| Jun 30, 2020 | -38,170.00 |
| Mar 31, 2020 | 272,639.00 |
| Dec 31, 2019 | 201,523.00 |
| Sep 30, 2019 | 298,032.00 |
| Jun 30, 2019 | 168,675.00 |